Brenda Wong
Neurology with Special Qualifications in Child Neurology · Worcester, MANPI 1609800267
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Pfizer at 50.5% of the total. Reporting peaked in 2019 at $11,638 and has fallen 81.6% since, to $2,137 in 2025. Among neurology with special qualifications in child neurology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 23 payments — averaging $769.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$9K
- Astellas Pharma Inc$2K
- ITF Therapeutics LLC$2K
- F. Hoffmann-la Roche AG$2K
- Eli Lilly$1K
- GSK$936
- plus $521 from 2 others
Across 122 payments — averaging $3685.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sarepta Therapeutics, Inc.$170K
- Astellas Pharma Inc$134K
- Roche Products Limited$70K
- Pfizer$55K
- GSK$16K
- F. Hoffmann-la Roche AG$5K
- plus $33 from 1 others
What the payments were for
- Consulting fees$6,90139%
- Speaking & faculty fees$9,17752%
- Travel & lodging$1,0676%
- Food & beverage$5623%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 10 | $8,936 |
| Astellas Pharma Inc | 1 | $2,415 |
| ITF Therapeutics LLC | 1 | $2,120 |
| F. Hoffmann-la Roche AG | 5 | $1,654 |
| Eli Lilly | 2 | $1,125 |
| GSK | 2 | $936 |
| Vertex | 1 | $500 |
| Astellas Pharma US Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Non-Covered Product$1,637
How this compares
$17,707 in reported general payments places this provider in the 90th percentile of 101 neurology with special qualifications in child neurology providers in Massachusetts.
See all neurology with special qualifications in child neurology providers in Massachusetts →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Exondys-51Eteplirsen | 50 | $3,138,891 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Worcester
- Christy StineWorcester$378
- Andrew DoughertyWorcester$115
- Elizabeth ThieleBoston$278K
- Jurriaan PetersBoston$265K
- Basil DarrasBoston$253K
- Kiran MaskiBoston$105K
- Phillip PearlBoston$50K
- Paul ChervinWoburn$36K
- Alexander RotenbergBoston$34K
- Irina AnselmBoston$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.